Introduction
Morphine has been proposed for the treatment of neuropathic pain. But it has incomplete efficacy and dose limiting adverse effects (Gilron et al., 2005) . To develop additional analgesics, derivatives have been synthesized by simplification and introduction of substituents into morphine's chemical structure (Corbett et al., 2006) . Thus, most morphine-derived opioid analgesics used clinically have μ-receptor agonist profiles.
Although all three major types of opioid receptors (μ, δ , and, κ ) are able to mediate analgesia and antinociception, they have different pharmacological activities. Recently, a prominent role of δ -opioid receptors in chronic pain such as neuropathic pain and inflammatory pain was reported using mutant animals and selective agonists (Nadal et al., 2006; Nozaki et al., 2012) . In a neuropathic pain rat model, δ -opioid receptor protein expression was increased compared to a sham operation in the dorsal root ganglion (Kabli and Cahill, 2007 ).
δ -opioid receptor activation leads to decreased chronic pain but weakly influences acute pain, in contrast to μ-opioid receptor activation (Gaveriaux et al., 2011) . A novel strategy for pain management is to use dual acting and/or mixed opioid agonists (Matsumoto et al., 2008; Cremeans et al., 2012) . Therefore, opioid agonists, which act on not only δ -but also μ-opioid receptor subtypes, might be broad-spectrum analgesics useful to treat a variety of painful conditions.
The traditional herbal medicine Mitragyna speciosa has long been used in Thailand for its opioid-like effects (Burkill, 1935) and as a replacement for opium (Suwanlert, 1975) . This medicinal herb contains many indole alkaloids (Takayama, 2004) . (E)-methyl 2- ((2S,3S,7aS,12bS)-3-ethyl-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12b-octahydroindolo[2,3-a] quinolizin-2-yl)-3-methoxyacrylate (7-hydroxymitragynine), a main active constituent of this plant, is an indole alkaloid that is structurally different from morphine (Horie et al., 2005) .
We have reported that 7-hydroxymitragynine induces a potent antinociceptive effect on mouse acute pain through the activation of μ-opioid receptors. It is about 14 times more potent than that of morphine when orally administered (Matsumoto et al., 2008) . Furthermore,
7-hydroxymitragynine inhibited gastrointestinal transit less potently than morphine at each
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JPET Fast Forward. Published on December 17, 2013 as DOI: 10.1124 at ASPET Journals on April 19, 2017 jpet.aspetjournals.org Downloaded from equally antinociceptive dose in mice (Matsumoto et al., 2006a) . We investigated the structural similarities between morphine and 7-hydroxymitragynine using molecular modeling techniques. However, we could not superimpose all three functional groups, i.e., a nitrogen atom, a benzene residue, and an oxygen atom on the benzene ring in their structures (Matsumoto et al., 2005a) . Therefore, we developed novel opioid analgesics derived from 7-hydroxymitragynine that has different pharmacophore groups from morphine that bind to μ-opioid receptors. We found a novel dual-acting μ-and κ -opioid agonist (E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1, 2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[ 2,3-a] quinolizin-2-yl)-3-methoxyacrylate (MGM-9) which has stronger antinociceptive and weaker rewarding effects than morphine (Matsumoto et al., 2008) .
7-Hydroxymitragynine-related indole alkaloids have interesting pharmacological profiles such as high oral potency and few side effects. Therefore, further investigation of the development of novel analgesics against acute and chronic pain is warranted.
In this study, we hypothesized that a dual-acting μ-and δ -opioid agonist derived from 7-hydroxymitragynine could not only induce potent antinociceptive effects against acute pain but also induce an anti-allodynic effect against neuropathic pain. We synthesized novel μ-/δ-opioid dual agonists (E)-methyl 2- ((2S,3S,7aS,12aR,12bS)-3-ethyl-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydr oindolo[2,3-a] quinolizin-2-yl)-3-methoxyacrylate (MGM-15) and (E)-methyl 2- ((2S,3S,7aS,12aR,12bS)-3-ethyl-9-fluoro-7a-hydroxy-8-methoxy-1,2,3,4,6,7,7a,12,12a,12b-decahydroindolo[2,3-a] quinolizin-2-yl)-3-methoxyacrylate (MGM-16) and clarified their pharmacological profiles using in vitro and in vivo experiments under physiological conditions. Furthermore, we examined the anti-allodynic effects of MGM-16 in a mouse sciatic nerve-ligation model. We found that the orally active μ-and JPET #208108 24 h, or 24 h before drug injection, respectively. These protocols were described by Matsumoto et al. (2005a) .
Animals.
Male ddY-strain mice (Japan SLC, Hamamatsu, Japan), male Hartley strain guinea-pigs (Japan SLC), and male SD rats (Japan SLC) were used. Animals were housed in a temperature-controlled room at 24°C with lights on from 07:00-19:00 and free access to food and water. All experiments were performed in compliance with the "Guiding Principles for the Care and Use of Laboratory Animals" approved by the Japanese Pharmacological Society and the guidelines approved by the Ethical Committee on Animal Care and Animal Experimentation of Josai International University. The number of animals used was kept to the minimum necessary for a meaningful interpretation of the data, and animal discomfort was kept to a minimum. Nihon Kohden, Tokyo, Japan). The effects of drug treatments on the twitch contractions evoked by transmural stimulation from the ring electrodes were examined. The height of the twitch response to transmural stimulation was measured before and after the drug challenge.
Responses were expressed as contraction % of the twitch response to the transmural stimulation before the drug challenge as 100%.
Electrical stimulation of mouse vas deferens. Mouse vas deferens was dissected and placed in Krebs-Henseleit solution without MgCl 2 . The tissues were placed under 0.2 g tension in a 10 mL organ bath containing the nutrient solution. The bath was maintained at 37°C and continuously bubbled with a mixture of 95% O 2 and 5% CO 2 . Tissues were stimulated by a platinum needle-ring (the ring was placed 20 mm above the base of a 5 mm long needle) electrode. After equilibration, the tissues were transmurally stimulated with a train of 10 pulses of 0.5 ms duration with 2 ms intervals every 1 min by a stimulator (SEN-7203, Nihon Kohden, Tokyo, Japan). Contractions were isometrically recorded by using a displacement transducer (TB-651T, Nihon Kohden, Tokyo, Japan). The effects of drug treatments on the twitch contractions evoked by transmural stimulation from the ring electrodes were examined. The height of the twitch response to transmural stimulation was measured before and after the drug challenge. The responses were expressed as contraction % of the twitch response to the transmural stimulation before the drug challenge as 100%.
Receptor binding. respectively, at 25°C. The reaction was terminated by rapid filtration under reduced pressure through glass fiber filters (Whatman GF/C, presoaked in 0.25% polyethyleneimine). After filtration, filters were washed three times with 3 mL of cold 50 mM Tris-HCl and counted in 4 mL of Ultima Gold scintillation cocktail (Perkin-Elmer, Boston, MA, USA). The ability of unlabeled drugs to inhibit specific radioligand binding was expressed as the IC 50 value, which is the molar concentration of the unlabeled drug necessary to displace 50% of the specific binding. Inhibition constants (Ki) of unlabeled compounds were calculated as described by Cheng and Prusoff (1973) . vehicle, and 30 min after oral administration of morphine or distilled water, a charcoal meal was orally administered. These time points were established by the time of peak effect for each drug and by the protocol as previously reported (Matsumoto et. al., 2006a) . Thirty minutes after administration of the charcoal meal, the animal was sacrificed by cervical dislocation, and the small intestine from the pylorus to the ileocecal junction was carefully removed. Both the length of the small intestine from the pylorus to the ileocecal junction and the farthest distance to which the charcoal meal had traveled were measured. Neuropathic pain model. The mice were anesthetized with 3% isoflurane. We produced a partial sciatic nerve injury by tying a tight ligature with an 8-0 silk suture around approximately one-third to one-half the diameter of the sciatic nerve on the right side (ipsilateral side) under a light microscope (SD30, Olympus, Tokyo, Japan), as described previously (Seltzer et al, 1990; Malmberg and Basbaum, 1998) . In sham-operated mice, the nerve was exposed without ligation. The sciatic nerve-ligated mice exhibit thermal hyperalgesia and mechanical hyperalgesia on the ipsilateral side, indicating the state of neuropathic pain hypersensitivity (Narita et al., 2008) . In the present study, the antinociceptive assay was performed 7 days after partial sciatic nerve-ligation.
Guanosine-5'-O-(3-thiotriphosphate) ([
Measurement of mechanical allodynia. The paw withdrawal threshold was determined as described by Chaplan et al. (1994) . The mice were individually placed in suspended cages with wire mesh bottoms and allowed to acclimate to their environment for at least 30 min.
The hind paw was stimulated with a series of calibrated (0.02-1.48 g) von Frey filaments applied to the plantar surface. The 50% paw withdrawal threshold that is non-parametrically distributed was determined using the up-down paradigm. Testing was initiated with 0.17 g This article has not been copyedited and formatted. The final version may differ from this version. 
Results
Effects of 7-hydroxymitragynine-related indole alkaloids on electrically-stimulated twitch contraction in guinea-pig ileum. The opioid agonistic activities of 7-hydroxymitragynine and semi-synthetic compounds derived from 7-hydroxymitragynine ( Fig. 1) were evaluated by measuring inhibition of the twitch contraction induced by electrical stimulation in the guinea-pig ileum preparation (Table 1) we investigated the effect of MGM-15 and MGM-16 using mouse vas deferens (Table 2) .
This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 2) . The curves of MGM-15 and MGM-16 were further shifted to the right in the presence of cyprodime, norBNI, and δ -selective antagonist naltrindole (Table 3) .
Receptor binding. The selective κ -opioid antagonist norBNI was ineffective against MGM-15-and MGM-16-induced antinociception. When these opioid antagonists were administered subcutaneously alone at the doses used in the present study, they did not produce any effects in the tail-flick test (data not shown).
Effect of MGM-16 on thermal hyperalgesia induced by sciatic nerve ligation in mice.
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MGM-16 (0.1, 0.2, and 0.4 mg/kg) dose-dependently increased the ipsilateral paw withdrawal threshold in sciatic nerve-ligated mice, and maximal anti-hyperalgesic responses were seen at 15 or 30 min after subcutaneous administration of MGM-16 (Fig. 6A) . MGM-16 (0.2 mg/kg) reversed the threshold to control level in sciatic nerve-ligated mice. In oral administration, MGM-16 (0.5, 1, and 2 mg/kg) dose-dependently increased the ipsilateral paw withdrawal threshold in sciatic nerve-ligated mice, and maximal anti-hyperalgesic responses were seen 30 min after administration (Fig. 6B) . MGM-16 at 1 mg/kg and gabapentin at 100 mg/kg reversed the threshold to control level in sciatic nerve-ligated mice.
To investigate the contribution of the opioid receptor subtypes in the anti-allodynic effect of MGM-16, sciatic nerve-ligated mice were pretreated with selective opioid receptor antagonists (Fig. 7) . The anti-allodynic effect of MGM-16 was completely blocked by β -FNA and naltrindole in the chronic pain model. The selective κ -opioid antagonist norBNI was ineffective against MGM-16-mediated antinociception.
Discussion
In the present study, we synthesized dual-acting μ-and is the first study to investigate the anti-allodynic effect of mitragynine-related indole alkaloids using a neuropathic mouse pain model.
The alkaloid, 7-hydroxymitragynine, was found to possess the most potent opioid agonistic effects among the constituents isolated from Thai herbal medicine Mitragyna speciosa (Horie et al., 2005) . We have previously synthesized opioid analgesics from the indole alkaloid mitragynine (Matsumoto et al., 2004 (Matsumoto et al., , 2008 Takayama et al., 2002 Takayama et al., , 2004 Takayama et al., , 2006 . We have surveyed these compounds for their opioid agonistic activities in vitro to elucidate the specific structure necessary for its pharmacophore to bind to opioid receptors. A nitrogen atom, a benzene residue, and an oxygen function play a significant role in producing opioid agonistic activity (Matsumoto et al., 2005a) . The conversion of an indolenine moiety in 7-hydroxymitragynine (MGM-15) and 10-fluoro-7-hydroxymitragynine into an indoline derivative (MGM-16) led to an increase in agonistic potency. This indicates that the sp 3 carbon at the C2 position ( Fig. 1) , which spatially configured the benzene ring in the ligands, was a more efficient at exerting the opioid activity. showed an increase in mechanical allodynia under neuropathic pain induced by partial sciatic nerve ligation (Nadal et al., 2006; Gaveriaux et al., 2011 also contribute to its anti-allodynic effect in partial sciatic nerve ligated mice.
The traditional Thai herbal medicine Mitragyna speciosa has long been used in Thailand for its opioid-like effects (Burkill, 1935) and as a replacement for opium (Suwanlert, 1975) .
We have studied the pharmacological activities of mitragynine, a major alkaloid of this herb (Watanabe et al., 1997; Matsumoto et al., 2005b) , and 7-hydroxymitragynine, a main active alkaloid of this herb (Matsumoto et al., 2004 (Matsumoto et al., , 2005a (Matsumoto et al., , 2006a . Recently, additional research has been performed on the opium-like effects of Mitragyna speciosa and mitragynine, and the unique chemical and pharmacological properties of mitragynine-related indole alkaloids (Adkins et al., 2011; Raffa et al., 2013) . We synthesized indole alkaloids such as the partial opioid agonist 9-hydroxycorynantheidine, opioid antagonist corynantheidine, and μ -/κ-dual agonist MGM-9. These compounds showed less rewarding effects, based on the structure-activity relationship study (Takayama et al, 2004 , Matsumoto et al., 2006b , 2008 .
In this study, we synthesized a novel Responses are expressed as contraction % of the twitch contraction before agonist addition.
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